Tumour Working Group and Cancer
Clinical Leads Forum
Monday 3rd December 2012
2
The London Cancer Alliance West and South
Welcome and Introduction
Prof Arnie Purushotham,
LCA Joint Interim Clinical Director
– Welcome
– Outline the purpose of the event
– Housekeeping
3
The London Cancer Alliance West and South
Clinical Leadership within the LCA
– Appointment process for Clinical Director and Associate
Clinical Director – interviews 11th December 2012
– Appointment process for Pathway Group Chairs
– 12 Pathway Groups (tumour specific only)
– Covering letter, advert, job description and job
specification emailed to CEOs, Medical Directors, Cancer
Clinical Leads and Cancer Nurse Leads
– Applicants to send a covering letter and CV emailed to
Claire Dowling LCA Programme Director
– Closing date for applications by 12 noon 24th December
2012
– Interviews to be held week commencing 21st & 28th
January 2013
– Interview panel to include Clinical Director, Associate
Clinical Director, Programme Director and Cancer Unit
representative from the Interim Clinical Board
– Questions?
4
The London Cancer Alliance West and South
LCA Progress to date
– Establishment of the Members Board and appointment of the
Independent Chairs for the Members Board and Clinical Board
– Progress against the Clinical Plan
– 1st Wave responses to the MoC
– Pan London agreement on best practice commissioning
pathways in colorectal, lung, brain/CNS and breast
– LCA wide best practice clinical guidelines in Breast, OG,
Lung, AOS, Survivorship & Palliative Care either agreed or
in final version ready for implementation January 2013
– Leading voice in pan London informatics agenda driving
progress in completeness of staging, SACT, TCR,
agreement of commissioning metrics and development of
LCA scorecards
– Macmillan project progress on Patient Experience, Patient
Information, Chemotherapy closer to Home & Survivorship
5
The London Cancer Alliance West and South
LCA Progress to date
– Emergency presentation audit underway
– Improved engagement and communication
including the final stages of development of
the LCA website, stakeholder engagement
forums across the pathway groups, AOS
simulation courses
– Development of the User Partnership agenda
across London
– Development of new systems and processes
for Peer Review and the wider quality agenda
6
The London Cancer Alliance West and South
But there is much more to do……..
– Appointment of Clinical Director & Associate Clinical Director
– Establishment of remaining pathway groups and appointment
of tumour-specific Pathway Group Chairs
– Delivery of the MoC recommendations in all pathway groups
– Promoting prevention and early detection of cancer by
supporting GPs and public health messages
– Development of the early diagnosis agenda & LCA endoscopy
– Delivery of significant improvement in patient experience and
patient information across all pathway groups
– Development and delivery of the LCA Medicines and
Chemotherapy agenda including chemotherapy closer to home
– Mental Health and Psychological medicine
– LCA Cancer research and training agenda
– Engagement with the CCGs
– Development and implementation of a communications
strategy
– Improved collaborative working across south and west London
Commissioning and
strategic priorities
Dr Kate Haire, LCA Clinical Commissioning
The London Cancer Alliance West and South
Cancer Commissioning Teams and London
Cancer Programme governance structure
Operating structure from 1 April 2013
The London Cancer Alliance West and South
Commissioning of cancer services
Model of Care for Cancer Services (NHS
London 2010)
London Cancer Programme: Strategic Themes
– Improving Early Detection
– Delivering care closer to home
– Consistency of care
– Consolidation of services
– Delivering productivity and efficiency
10
The London Cancer Alliance West and South
LCA Strategic Priorities
– Work with London Cancer Programmes to develop 3 year
plan for delivery of Model of Care
– LCA Clinical Service Plan
– LCA Strategic Priorities: Pathway specific and cross cutting
priorities
– Key
•
•
•
•
•
issues
Flexibility to take account of emerging priorities
Work of London Cancer Integrated Cancer System
Commissioning arrangements from 2013
Resources
Wider political context
Preparation for
Peer Review
Mr Nick Hyde, Cancer Director St George’s Healthcare NHS
Trust
12
The London Cancer Alliance West and South
LCA Peer Review Progress
– Transition of the SE, SW & NW Cancer
Network provider functions to the LCA
– Mapping of current peer review measures
across to LCA structures and processes
– LCA Peer Review Transition Plan in final draft
– Network Board measures transfer to Joint
Development Group due to composition and
function of JDG
– Existing TWG arrangements remain in place
with accountability to the Pathway groups and
Clinical Board
– Approach maintains oversight & guidance to
MDTs until 31st March; assurance to peer
review
13
The London Cancer Alliance West and South
Proposed Transitionary Configuration
Current Configuration
Children’s Cancer Network
Commissioning Function
(8A)
Local Area Team (LAT) or
NHS Commissioning
Board
LCA Members Board (MB)
Cancer Network Board
(1A)
Children and Young
People (7A)
Joint Development
Group (JDG)
LCA Research Board
Cancer Research Network
(5A)
LCA Clinical Board (CB)
Network Cross Cutting
Groups (1E)
Pathway Groups (PGs)
Original 3 Tumour
Working Groups
(TWGs) remain in place
as interim solution 1st
October to 1st April 2013
Network Site Specific
Groups / Tumour Working
Groups (NSSG / TWG)
(1C)
Cross Cutting Groups
(3R-Z)
Children’s CN and TYA
CN (7B, C, D)
Multi Disciplinary Teams (MDTs)
Cross Cutting Groups and CYP
CNs : Trust Level
Multi Disciplinary Teams
(MDTs) (2B-M)
Localities (1D)
Local
Trust Level / CCG / Local
Borough Teams
PCTs Chemotherapy Community (6A adults
and Children)
14
The London Cancer Alliance West and South
LCA Peer Review Progress
– From April 1st TWG meetings will be replaced
with Pathway Group led quarterly tumour
specific clinical forums – ensures compliance
to 1c measures
– These quarterly forums will ensure clinical
governance is at the heart of the LCA and will
facilitate - clinical audit/clinical effectiveness
- patient safety/ patient experience
- clinical research
- training and education
- user involvement and service
improvement
- vertical communication
15
The London Cancer Alliance West and South
LCA Peer Review 2013/14
– Collaborative partnership working with NCAT
– Development of a “Skinny” Peer Review–
essential components to assure quality
standards, systems and processes across the
LCA
– Development of a Pathway Group Constitution
to include:
- operational policy
- an annual report
- work plan
– Any Questions?
NCAT Plans and
Legacy
Ms Ruth Bridgeman, National Programme Director, Peer
Review
The London Cancer Alliance West and South
New Improvement Body (nIB)
• Will bring together several legacy organisations
– NHS Institute
– NHS Improvement
– National Cancer Action Team
– End of Life Care Programme
– NHS Diabetes and Kidney
– National Technology Adoption Centre
• Work programme will be based around priorities
identified by the 5 Domain Directors
• Julian Hartley appointed as Interim Managing
Director
The London Cancer Alliance West and South
Business Continuity
– Some programmes of work will transfer to the
nIB
– Some programmes will close because the work
is completed
– Some programmes will need to continue and a
suitable host will need to be found for it i.e.
National Cancer Peer Review Programme
– Some programmes will be discontinued
– We need to capture the learning from all the
work we have done.
– We need to ensure that the learning is passed
on to successor organisations
The London Cancer Alliance West and South
Transition Delivery Partner (TDP)
– Will be established to continue some of the
work of existing programmes and to
commence delivery on new areas of work
– TDP will exist for a period up to one year from
April 2013 to March 2014
– Work programme will emerge from the nIB
Business Plan
– It is proposed that the National Cancer Peer
Review Programme will initially form part of
the TDP
20
The London Cancer Alliance West and South
Change Presentation title and date in Footer dd.mm.yyyy
Developing the future Peer Review
Programme
– Greater focus on Outcomes
– Using Service Profiles
– Limited data available currently
– Fewer Measures
– Some process measures will be required
– Minimising the evidence required
– Operational Policy
– Annual Report
– Work Programme
– Greater Transparency of the reports
– My Cancer Treatment
21
The London Cancer Alliance West and South
Change Presentation title and date in Footer dd.mm.yyyy
22
The London Cancer Alliance West and South
Change Presentation title and date in Footer dd.mm.yyyy
The London Cancer Alliance West and South
Click here
to view the
full report
Peer Review –
break out session
Mr Nick Hyde, Cancer Director St George’s Healthcare NHS
Trust
25
The London Cancer Alliance West and South
Break out session – 30 mins brainstorm
15 mins feedback session
What are the essential components of Peer
Review?
– Innovative ways of working
– What’s new that can be applied to Peer Review
in 2013
– Essential documentation
– Essential structures, systems and processes
– Essential feedback mechanisms
– Assurance across 17 provider organisations
Closing Remarks
Mr Justin Vale, Joint Interim Clinical Director